Close
Smartlab Europe
Inizio Ignite

News

Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden

Mural Health, a clinical trials technology company that improves the patient and caregiver experience in clinical trials, has today announced a strategic partnership with ClinOne, the leading provider of adaptive clinical trial experience solutions. The move will integrate Mural...

Canton of Geneva supports Connect in Pharma 2023

The Canton of Geneva has announced its official support for Connect in Pharma 2023, a Geneva-based event bringing together European leaders in pharmaceuticals and healthcare to discuss the future of the global pharma and biopharma sector. Connect in Pharma’s...

Significance Of Mentorship for Healthcare Professionals

For years, the healthcare industry has been categorized as one of the world's most challenging, stressful, and yet somehow exciting industries. It also ranks high in knowledge, advancement, and having qualified personnel who know how to deal with complex...

Diosynvax Offers Lasting Defense Against COVID-19 Variants

Researchers have created a novel Covid-19 vaccine called DIOSynVax that can be administered using air-jet technology rather than a needle. This revolutionary vaccine aims to provide long-lasting protection against not only SARS-CoV-2 but also other related diseases. Traditionally, the body's...

Overactive Protein Responsible For Severe Skin Disorder

A significant breakthrough has been made by researchers from the National Institutes of Health (NIH) in collaboration with scientists from the University of California San Diego (UCSD) and the University of Pittsburgh in understanding and potentially treating a rare...

New Drug Extends Treatment Duration For Glioma Patients

The University of California scientists have discovered a new targeted therapy drug that can extend the treatment duration for individuals with a specific subtype of glioma, a deadly brain tumor. The drug, vorasidenib, was found to more than double...

Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform

Anaqua, the leading innovation and intellectual property (IP) management technology provider announced that global medical technology company Getinge has selected Anaqua’s AQX in order to consolidate the management of all its IP assets onto a single, centralized platform. Founded in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »